Credit Suisse’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $837K | Buy |
+22,056
| New | +$837K | ﹤0.01% | 2373 |
|
|
2022
Q3 | – | Sell |
-1
| Closed | – | – | 4261 |
|
|
2022
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4283 |
|
|
2021
Q1 | – | Sell |
-464
| Closed | -$91K | – | 3550 |
|
|
2020
Q4 | $91K | Buy |
+464
| New | +$91K | ﹤0.01% | 3337 |
|
|
2016
Q4 | – | Sell |
-400
| Closed | -$64K | – | 3796 |
|
|
2016
Q3 | $64K | Buy |
+400
| New | +$64K | ﹤0.01% | 3646 |
|